(Q57708611)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331192%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Adenosine/dopamine interaction: implications for the treatment of Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331192%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331192%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Christa E Müller

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331192%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Sven Ove Ögren

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331192%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Kjell Fuxe

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331192%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

P Popoli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331192%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

L Giménez-Llort

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331192%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

R Rimondini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331192%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

I Strömberg

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331192%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 July 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331192%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

number of pages

7

1 reference

Parkinsonism and Related Disorders

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331192%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331192%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331192%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

235-241

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331192%20AND%20SRC:MED&resulttype=core&format=json

Adenosine-dopamine interactions in the brain

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Adenosine-dopamine interactions in the ventral striatum. Implications for the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Dopamine D1 receptor-mediated facilitation of GABAergic neurotransmission in the rat strioentopenduncular pathway and its modulation by adenosine A1 receptor-mediated mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

D1 and D2 dopamine receptor gene expression in the rat striatum: Sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAS in distinct neuronal populations of the dorsal and ventral striatum

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

D1 and D2 dopamine receptors differentially increase Fos-like immunoreactivity in accumbal projections to the ventral pallidum and midbrain

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Cellular expression of adenosine A2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Differential effects of selective adenosine A1 and A2A receptor agonists on dopamine receptor agonist-induced behavioural responses in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Antagonistic interaction between adenosine A2A receptors and dopamine D2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Opposing actions of adenosine A2a and dopamine D2 receptor activation on GABA release in the basal ganglia: evidence for an A2a/D2 receptor interaction in globus pallidus.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Modulation of endogenous GABA release by an antagonistic adenosine A1/dopamineD1 receptor interaction in rat brain limbic regions but not basal ganglia.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Adenosine A2A and group I metabotropic glutamate receptors synergistically modulate the binding characteristics of dopamine D2 receptors in the rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Desensitisation of the adenosine A1 receptor by the A2A receptor in the rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Receptor-receptor interactions as an integrative mechanism in nerve cells

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Recent advances in the molecular biology of dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Purinoceptors in the nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Involvement of adenosine and glutamate receptors in the induction of c-fos in the striatum by haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Adenosine A2 receptors stimulate c-fos expression in striatal neurons of 6-hydroxydopamine-lesioned rats

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Adenosine A2A receptors modulate the binding characteristics of dopamine D2 receptors in stably cotransfected fibroblast cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Adenosine A1 receptor-mediated modulation of dopamine D1 receptors in stably cotransfected fibroblast cells

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Reciprocal interactions between adenosine A2A and dopamine D2 receptors in Chinese hamster ovary cells co-transfected with the two receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Activation of adenosine A1 and A2A receptors modulates dopamine D2 receptor-induced responses in stably transfected human neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Antagonism of adenosine A2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

8-(3-Chlorostyryl)caffeine (CSC) is a selective A2-adenosine antagonist in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Adenosine A1 and A2A receptor antagonists stimulate motor activity: evidence for an increased effectiveness in aged rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Dopamine-independent and adenosine-dependent mechanisms involved in the effects of N-methyl-D-aspartate on motor activity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Adenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Rotational behaviour elicited by intracerebral injections of apomorphine and pergolide in 6-hydroxy-dopamine-lesioned rats. I: Comparison between systemic and intrastriatal injections.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Adenosine receptor antagonists potentiate dopamine receptor agonist-induced rotational behavior in 6-hydroxydopamine-lesioned rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Blockade of A2aAdenosine Receptors Positively Modulates Turning Behaviour and c-Fos Expression Induced by D1Agonists in Dopamine-denervated Rats

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Adenosine A1 receptor blockade selectively potentiates the motor effects induced by dopamine D1 receptor stimulation in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Stimulation of adenosine A1 receptors attenuates dopamine D1 receptor-mediated increase of NGFI-A, c-fos and jun-B mRNA levels in the dopamine-denervated striatum and dopamine D1 receptor-mediated turning behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Dopamine denervation leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Locomotor-activating effects of the D2 agonist bromocriptine show environment-specific sensitization following repeated injections

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Agonist-induced homologous and heterologous sensitization to D-1- and D-2-dependent contraversive turning

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Motor stimulant effects of caffeine in 6-hydroxydopamine-lesioned rats are dependent on previous stimulation of dopamine receptors: a different role of D1 and D2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Lack of cross-sensitization between the locomotor-activating effects of bromocriptine and those of cocaine or heroin.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Complete, reversible, drug-specific tolerance to stimulation of locomotor activity by caffeine

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Tolerance to behavioral effects of caffeine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Development of tolerance to dopaminergic stimulating effect of theophylline in mice with unilateral striatal 6-hydroxydopamine lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Adenosine receptor ligands: differences with acute versus chronic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

Repeated co-administration of caffeine and bromocriptine prevents tolerance to the effects of caffeine in the turning behavior animal model

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900063-8

7 January 2021

10.1016/S1353-8020(00)00063-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331192%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference